top of page

Search

Upcoming FDA, SAMHSA Discussion on Naloxone Access

Ann Tucker

Nov 18, 20221 min read

You are invited to participate in a stakeholder call to discuss naloxone access on November 28 at 2:30pm ET. Speakers will include FDA Commissioner Dr. Robert Califf and Marta Sokolowska, FDA Deputy Director for Substance Use and Behavioral Health. Dr. Miriam Delphin-Rittmon, SAMHSA Assistant Secretary for Mental Health and Substance Use, will also participate on the call. Read more

Recent Posts

New Practical Guide Released on Advising Patients on Using 988 vs. 911

SAMHSA [12/19] – SAMHSA has issued a new Practical Guide: Advising People on Using 988 Versus 911 to help in better understanding the...

New Mental Health Rule Introduces Employer Benefit Parity Test

Bloomberg Government [9/09] - The Biden administration is poised to issue a final rule toughening mandates for employer-sponsored health...

Sackler Family Risks Litigation After Supreme Court Rejects Purdue Pharma Settlement

Forbes [7/09] - Purdue Pharma went back to court this week after the Supreme Court thwarted the OxyContin maker’s...

Comments

Back to Top

bottom of page